Table 3.
The effects of endoscopic therapies on variceal recurrence after esophageal variceal eradication
| EVL group (n = 54) |
EIS group (n = 80) |
EVL + EIS group (n = 19) |
P value | |
|---|---|---|---|---|
| Course number of endoscopic treatment course to variceal eradication | 1.9 ± 0.7 | 3.2 ± 1.2a | 3.4 ± 1.6a | 0.00 |
| Median time of variceal recurrence(month) | 10 | 13a | 12 | 0.01 |
| EUS findings | ||||
| diameter of peri-ECV(mm) | 2.9 ± 1.4 | 3.4 ± 1.5 | 2.9 ± 1.1 | 0.14 |
| diameter of PFV(mm) | 1.44 ± 1.5 | 0.9 ± 1.5 | 1.0 ± 1.3 | 0.15 |
| existence or not of PFV(Y/N,n) | 29/25 | 24/56a | 6/13 | 0.01 |
| diameter of para-ECV(mm) | 6.2 ± 2.1 | 6.3 ± 2.3 | 6.3 ± 2.4 | 0.83 |
| Esophageal stenosis(Y/N,n) | 0/54 | 9/71a | 0/19 | 0.01 |
| Child-Pugh grade(n,%) | 0.21 | |||
| A | 29, 53.7 | 57, 71.3 | 10, 52.6 | |
| B | 20, 37.0 | 16, 20 | 7, 36.9 | |
| C | 5, 9.3 | 7, 8.7 | 2, 10.5 | |
| Child-Pugh score | 7.2 ± 2.1 | 6.7 ± 1.7 | 7.2 ± 1.9 | 0.36 |
| Portal vein embolus(Y/N, n) | 10/44 | 24/56 | 4/15 | 0.29 |
| With liver cancer (n,%) | 7, 13.0 | 9, 11.3 | 3,15.8 | 0.85 |
| Unknown causes for cirrhosis | 0 | 2 | 1 | |
aCompared with EVL group